首页 / 专利分类库 / 有机化学 / 杂环化合物 / 杂环化合物,含喹啉或氢化喹啉环系
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
181 JPH05500218A - JP51302390 1990-09-04 JPH05500218A 1993-01-21
182 JPH0450313B2 - JP19774383 1983-10-21 JPH0450313B2 1992-08-13 MATSUMOTO JUNICHI; MYAMOTO KOSHI; UNO JUN; NAKAMURA SHINICHI
183 Intermediate useful for preparation of nitrogen-containing polycyclic compound JP5358791 1991-02-27 JPH04210961A 1992-08-03 TAUNREE PII KARUBAATOSON; JIYON EMU DOOMAGARA; TOMASU EFU MITSUKU; JIEFURII BII NIKORUSU
PURPOSE: To provide an intermediate useful for the production of a nitrogen- containing polycyclic compound used for treating bacterial infections. CONSTITUTION: (A) 3-Pyrrolidinemethanamines of formula I [R 3 is 1-4C alkyl, 3-6C cycloalkyl; R 4 is H, 1-4C alkyl, 2-4C hydroxyalkyl or R 7CO-C (R 7 is 1-4C alkyl or 1-4C alkoxy]. (B) 2,7-Diazaspiro[4,4]nonane of formula II. (C) Ethyl[(3- pyrolidinyl)methyl] carbamate. (D) A compound of formula III (R 1 is H, 1-6C alkyl or cation; R 2 is 1-4C alkyl, vinyl, 2-4C haloalkyl or 2-4C hydroxyalkyl; X is CH, CCl, CF, C-OH, CO-1-3C alkyl, CNH-1-3C alkyl-N; and Y is H, F, Cl or Br) or IV (R 8 and R 9 are H or 1-3C alkyl). COPYRIGHT: (C)1992,JPO
184 JPH0414676B2 - JP26844384 1984-12-21 JPH0414676B2 1992-03-13 HASEGAWA YOSHIHIRO; KURYAMA TAKASHI; SHIMOMURA HATSUSHI; SUGAI SABURO; OKAZAKI TOKUJI; KAJIWARA YOSHIO; KIMURA TOMONORI; KAWADA TOMIE; KANBARA TOSHIBUMI; NAITO YASUO; YOSHIDA SEIICHIRO; AKABOSHI MITSUYA; IKEGAMI
185 JPH041747B2 - JP26543686 1986-11-07 JPH041747B2 1992-01-14 BANAUARA RAKUSHUMANA MIRARI; ERITSUKU ROBAATO RAASON; UIRIAMU JEI ZEMUBUROSUKII
186 Azabicycloquinolonecarboxylic acid JP21646190 1990-08-16 JPH0386875A 1991-04-11 KIYASARIN ERIZABESU BURAITEI
NEW MATERIAL: A compd. of formula I, [where R 1 is H, a cation or an alkyl; Y is ethyl, t-butyl, vinyl or cyclopropyl; W is H, F, Cl, Br, an alkyl or amino; A is CH, CF, C-CN or N; A is C which composes a five- or six-membered ring together with Y and C and N, which are combined with Y; R 2 is formula II or III, (where R 3 to R 7, R 9, R 10 and R 25 are each H, CH 3, CH 2NH 2 or CH 2 NHCH 3, and in add., R 5 to R 7 and R 9 are each NH 2, NHCH 3 or NHC 2H 5, on the condition that up to three of them are groups other than H)]. EXAMPLE: 7-(1-Amino-3-azabicyclo[3. 1. 0] hex-3-yl)-6-fluoro-1-(2,4- difluorophenyl)-1,4-dihydro-4oxo-1,8-naphthylidine-3-carboxylic acid. USE: As an antibactericide useful for the medical treatment of gram-positive infection. PROCESS: The compd. of formula I is obtd. by allowing a compd. of formula IV, (where X is an elimination group), to react with a compd. of the formula (R 2H). COPYRIGHT: (C)1991,JPO
187 JPH0130823B2 - JP12302480 1980-09-05 JPH0130823B2 1989-06-22 IRIKURA TSUTOMU; SHIBA TOSHE; MATSUKUBO HIROSHI
188 Quinoline based compound, production thereof and anticancer agent containing said compound as active ingredient JP6976687 1987-03-24 JPS63238079A 1988-10-04 YAMATO MASATOSHI
NEW MATERIAL:A compound expressed by formula I (X is O or S). EXAMPLE:N-{4-[ (Benzoflo[3,2-b]quinoline-11yl)amino ]-3-methoxyphenyl}metha nesulfoneamide. USE:An anticancer agent. PREPARATION:A compound expressed by formula II is reacted with N-(4- amino-3-methoxyphenyl)methanesulfoneamide while stirring under heat and reflux to provide the aimed compound expressed by formula I.
189 Production of n-alkylquinolonecarboxylic acid derivative JP2749787 1987-02-09 JPS63196589A 1988-08-15 NISHIDA HIROSHI; MAGARA OSAMU; UMEMURA TAKEAKI
PURPOSE: To industrially and advantageously obtain a precursor for N- alkylquinolonecarboxylic acids useful as agricultural germicides, etc., by thermally rearranging a specific 4-alkoxyquinolinecarboxylic acid ester in the presence of a specific onium salt. CONSTITUTION: A 4-alkoxyquinolinecarboxylic acid ester expressed by formula I [R 1 and R 2 are lower alkyl; R 3 is H or lower alkyl; A is H, halogen, lower alkyl, lower alkoxy, trifluoromethyl, trifluoromethoxy, -OCH 2O- (at the 6,7- positions) or formula II (at the 5,6-positions; R 4 is lower alkyl)] is thermally rearranged in the presence of an onium salt expressed by the formula R 3(R 4) 3NX or (R 5) 3SX (R 3 and R 4 are lower alkyl or benzyl; R 5 is lower alkyl; X is halogen) in a molar amount of preferably 0.02W0.1 based on the ester expressed by formula I, preferably at 120W150°C to afford the aimed compound expressed by formula III. COPYRIGHT: (C)1988,JPO&Japio
190 2-amino-1,3,4-thiadiazole derivative and antiulcer agent containing said derivative as active component JP17184686 1986-07-23 JPS63190886A 1988-08-08 HASEGAWA YOSHIHIRO; HOSAKA KUNIO; TAKEDA SHIGEFUMI; MIHASHI HIROSHI
NEW MATERIAL:The compound of formula (R is pyridylmethylthio, pyridylmethylsulfinyl, pyridylthiomethyl or quinolylmethylthio). EXAMPLE:2-Amino-5-(2-pyridylmethylthio)-1,3,4-thiadiazole. USE:an antitumor agent. PREPARATION:The objective compound can be produced by reacting 2-amino-5- mercapto-1,3,4-thiadiazole with a compound of formula ClCH2-X (X is pyridyl or 4-quinolyl) (e.g. 2-picolyl chloride hydrochloride) in the presence of a base (e.g. sodium hydroxide) using a phase-transfer catalyst (e.g. tetra-n- butylammonium bromide). The reaction solvent is preferably a mixture of water and a water-insoluble organic solvent such as benzene.
191 JPS6256151B2 - JP17127183 1983-09-19 JPS6256151B2 1987-11-24 ITO YASUO; KATO HIDEO; OGAWA NOBUO; ETSUCHU EIICHI; SUZUKI TOMIO; YAGI NORYUKI
192 Quinolone derivative JP10668486 1986-05-12 JPS62263157A 1987-11-16 SHIMIZU SHIGEO; YAGIHASHI FUJIO; TAKANO HIROYUKI
NEW MATERIAL:The compound of formula I [R<1> is halogen, (substituted) cyclic amino or imidazolyl; R<2> is alkyl which may be substituted with halogen or OH; R<3> is lower alkyl) and its salt. EXAMPLE:1-Ethyl-3-carboxy-6,7-difluoro-8-methoxy-4-quinolone. USE:An antibacterial agent. PREPARATION:The objective compound of formula I can be produced by (1) reacting the compound of formula II with R<3>ONa, (2) reducing the reaction product, (3) reacting with diethyl ethoxymethylenemalonate of formula C2H5OCH =C(COOC2H5)2, (4) contacting the resultant compound of formula III with NaH in a solvent such as DMF, (5) adding a compound of formula R<2>-X to the system after ceasing the generation of hydrogen, thereby introducing a substituent group R<2> to N atom, (6) treating the product at 60-120 deg.C in a polyphosphoric acid ester to effect cyclization and (7) subjecting the obtained compound of formula IV to hydrolysis, etc.
193 Novel quinolone derivative, ester and salt thereof JP7166786 1986-03-28 JPS62226962A 1987-10-05 MIYAMOTO KOSHI; KATAOKA MASAHIRO; NAKANO JUNJI; MATSUMOTO JUNICHI; NAKAMURA SHINICHI
NEW MATERIAL:A quinolone derivative of formula I [X1 and X2 are H or halogen; Y is O or S; R1 is H, lower alkyl or benzyl; R2 is halogen, lower mono- or dialkylamino, group of formula II or formula III (Z is O, S or R8-N; R4-R6 and R8 are H or lower alkyl; R7 is H, hydroxyl, amino, lower mono- or dialkylamino, etc.); R3 is lower alkyl, lower alkenyl etc.; n is 3-5], its ester and salt. EXAMPLE:5-Benzyloxy-1-cyclopropyl-6, 7, 8-trifluoro-1,4-dihydro-4- oxoquinoline-3- carboxylic acid ethyl ester. USE:Useful as an antibacterial agent. Also useful as a drug for man and animal, drug for fish disease, agricultural chemical, food preservative, etc. PREPARATION:The compound of formula I can be produced e.g. by reacting a novel compound of formula IV (X3 is halogen) with a compound of formula V in the presence of a base.
194 Quinoline-3-carboxylic acid derivative JP1675886 1986-01-30 JPS62178586A 1987-08-05 ITO YASUO; KATO HIDEO; ETSUCHU EIICHI; OGAWA NOBUO; YAGI NORIYUKI
NEW MATERIAL:A compound expressed by formula I (R1 is lower alkyl; R2 is H or lower alkanoyl; R3 is lower alkyl) and salt thereof. EXAMPLE:7-( 4-Acetyl-3-methyl-1-piperazinyl )-8-chloro-1-ethyl-6-fluoro-1, 4,-dihydro-4- quinoline-3-carboxylic acid. USE:An antimicrobial agent. PREPARATION:The 8-position of a quinoline-3-carboxylic acid derivative expressed by formula III, e.g. 7-(4-acetyl-3-methyl-1-piperazinyl)-1-ethyl-6- fluoro-1,4-di-hydro-4-oxoquinoline-3-carboxylic acid, etc., is directly chlorinated with a chlorinating agent, e.g. chlorine, sulfuryl chloride, etc.
195 Heterocyclic ring-containing polymeric compound and its production JP29460185 1985-12-27 JPS62153321A 1987-07-08 NIWA TAKAKAZU; KUROHARA TAKAYUKI; MOTOYAMA YUKIO
PURPOSE:To obtain a heterocyclic ring-containing polymeric compound having high physical strength, high heat resistance and good moldability, by condensing a specified heterocyclic ring-containing tetracarboxylic acid dianhydride with a specified diamine. CONSTITUTION:A heterocyclic ring-containing tetracarboxylic acid dianhydride of formula I is condensed with a diamine of the formula: H2N-R'-NH2 to obtain a heterocyclic ring-containing polymeric compound of formula II. In the formu lae, R is a 4-21C tetravalent organic residue, R1 and R2 are each H, methyl or phenyl, A is a pyridine, dipyridine, imidazole or quinoline ring which may have a substituent, R' is a 2 C or higher bivalent organic residue and n >=1. The compound of formula II can be obtained by condensing the heterocyclic compound of formula III with the tetracarboxylic acid dianhydride of formula III in the presence of a catalyst.
196 Selective herbicide JP28970185 1985-12-23 JPS62148470A 1987-07-02 ONODERA NOBUO; SOMEYA SHINZO
NEW MATERIAL:The ketoxime derivative of formula I [R 1 is lower alkyl; R 2 is lower alkyl or lower alkoxycarbonylalkyl; R 1 and R 2 may together form -(CH 2) 4- or -(CH 2) 5- which may be substituted with methyl group and one of the -CH 2- groups may be substituted with S]. EXAMPLE: 3,7-Dichloroquinoline-8-carboxylic acid acetoxime ester. USE: Useful as a herbicide. It can be safely applied to rice plant (grown in dry field or paddy field) which is a gramineous crop. It is effective in controlling gramineous weeds such as cockspur-grass, green foxtail, etc. Especially, cockspur-grass can be completely exterminated with said herbicide. PREPARATION: The compound of formula I can be produced by reacting an active compound of 3,7-dichloroquinoline-8-carboxylic acid with a ketoxime derivative of formula II. COPYRIGHT: (C)1987,JPO&Japio
197 Heterocyclic compound and manufacture JP24330486 1986-10-15 JPS62135462A 1987-06-18 DEIBITSUDO KOTSUKUSU; DEIBITSUDO EDOWAADO HOORU; ANTONII HAWAADO INGOORU; JIYON RUISU SASUCHITSUKII
198 Tetrahydroquinoline derivative JP25248985 1985-11-11 JPS62103080A 1987-05-13 UCHIDA MINORU; MORITA SEIJI; CHIHIRO MASATOSHI; NAKAGAWA KAZUYUKI
NEW MATERIAL:A compound shown by the formula I[R<1> and R<2> are H, alkyl, alkoxy, halogen, OH, alkenyloxy, alkynyloxy or alkoxyalkoxy; R<3> and R<4> are H, halogen, (halogen-substituted)alkyl, alkoxy, NO2 or alkanoyl; A and B are alkylene; l, m and n are 0 or 1] and its salt. EXAMPLE:5-(5-Methoxy-2-benzimidazolyl)-sulfinyl-5,6,7,8-tetrahydroquin oline. USE:Having antiulcer action, useful as a remedy for ulcers of digestive organ such as gastric ulcer, duodenal ulcer, etc. PREPARATION:For example, a compound shown by the formula II is reacted with a compound shown by the formula III(one of X1 and X2 is mercapto and the other is halogen, alkanesulfonyloxy, etc.,) in a proper solvent in the presence of a basic compound, to give a compound shown by the formula I where lis 0.
199 Quinophthalone dye JP21286086 1986-09-11 JPS6296571A 1987-05-06 UORUFUGANGU ROTSUCHIYU; PEETAA NOIMAN; HAINRITSUHI KOBUARUSHIYU
200 Quinazoline derivative and pharmaceutical JP20446385 1985-09-18 JPS6267077A 1987-03-26 YOKOYAMA KEIICHI; ONO HIROYASU; KATOU KOUJI; KITAHARA TAKUMI; NISHINA TAKASHI; WATANABE KAZUYUKI; SARUTA SAKAE; KUMAKURA MIKIO; AWAYA AKIRA; NAKANO TAKUO
NEW MATERIAL:The compound of formula I [Het is group of formula II (R<1> is alkyl, cycloalkyl, OH-substituted lower alkyl, aralkyl, etc.), formula III (R<3> and R<4> are lower lakoxy, OH, lower alkylamino, etc.), formula IV, formula V, etc.] or its pharmacologically permissible salt. EXAMPLE:4-Amino-6, 7-dimethoxy-2-[ 4-( 2-methyl-3-oxo-2, 3-dihydro-1 H-pyrazolo[3,4- d]pyrimidin-6-yl) piperazino] quinazoline hydrochloride. USE:Medicine. Hypotensor. It has strong and long-acting hypotensive effect. The orthostatic hypotension which is an undesirable side effect caused by rapid lowering of blood tension is alleviated or suppressed almost completely in the present hypotensor. the agent is expected to have a remedying effect to cardiac insufficiency. PREPARATION:The objective compound of formula I can be produced by reacting the compound of formula IV with the compound of formula VII in a solvent such as isoamyl alcohol at 100-150 deg.C for 1-6 hr under refluxing.
QQ群二维码
意见反馈